RAD51AP1 and colorectal carcinoma: Interestingly, we also found that cancer with higher RAD51AP1 expression often presented higher MSI (Figure 11A), which is positively correlated to ICIs therapy efficacy in CRC and other cancers (Dudley et al., 2016).